Douglas Lane & Associates’s Opko Health OPK Stock Holding History

Douglas Lane & Associates’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,000	Closed	-$42K	–	222
2018 Q4	$42K	Buy	+14,000	New	+$47.5K	﹤0.01%	216
2016 Q4	–	Sell	-10,000	Closed	-$106K	–	213
2016 Q3	$106K	Sell	10,000 -5,000	-33%	-$49.8K	﹤0.01%	206
2016 Q2	$140K	Hold	15,000	–	–	﹤0.01%	211
2016 Q1	$156K	Buy	+15,000	New	+$137K	﹤0.01%	212

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Douglas Lane & Associates's OPK Position: Q1 2019 in Review

Douglas Lane & Associates sold out of Opko Health (OPK) in Q1 2019, closing a stake of 14,000 shares — an estimated $42K sold.

Douglas Lane & Associates first reported a position in OPK in Q1 2016 and held it in 4 quarters. The position peaked at $156K in Q1 2016. 201 funds tracked by Wall St. Rank hold OPK as of Q1 2019.

Douglas Lane & Associates reported no remaining Opko Health position as of Q1 2019 after selling out during the quarter.
Douglas Lane & Associates sold 14,000 Opko Health shares in Q1 2019, an estimated $42K.
Douglas Lane & Associates first reported a position in Opko Health in Q1 2016 and held it in 4 quarters.
Douglas Lane & Associates's Opko Health position peaked at $156K in Q1 2016.
201 funds tracked by Wall St. Rank held Opko Health as of Q1 2019.

Based on Douglas Lane & Associates's 13F filing for Q1 2019, filed 23 Apr 2019.